TCRT

NASD Alaunos Therapeutics, Inc.
Oct 21, 2026 · 6:06 PM ET LAST TRADE Market Closed

$3.10 ↑ +0.02 (+0.64%) Trading Up from the previous close of $3.08, $0.23 below the day’s high of $3.33

YTD change
-4.04%
vs 20-day SMA
+113.91%
vs 200-day SMA
+31.21%

Price ranges

Previous day
$2.76 $3.26
open $2.77 close $2.97
+$0.20 (+7.22%)
Today
$2.81 $3.33
open $3.13 now $3.10
-$0.03 (-0.97%)
Past week
$1.80 $4.40
from $3.03 now $3.10
+$0.07 (+2.30%)
Past month
$0.72 $4.40
from $1.27 now $3.10
+$1.83 (+144.06%)
This year
$0.72 $4.40
from $3.23 now $3.10
-$0.13 (-4.04%)

Price & Performance

+0.19 (+6.83%) / 6M

$0.5515$1.47$2.40$3.32Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 99.5% away from all-time highs of $601.50
  • TCRT is down 4% since the beginning of the year
  • TCRT is up 12% over the past 12 months
  • TCRT is up 144% over the past 1 month
  • 0% of all TCRT investors are betting against TCRT

TCRT reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +7.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.4063
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $7.1M
Beta 1.54

Balance sheet & scale

IncomeN/A
Revenue$3.0K
Cash$124.0K
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $12.8M

Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Fort Lauderdale, FL.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $438.94 +3.29%
MRNA Moderna, Inc. $242.08 +6.69%
RVMD Revolution Medicines, Inc. $196.55 +7.91%
ROIV Roivant Sciences Ltd. $34.92 +0.63%
BNTX BioNTech SE Sponsored ADR $91.17 +2.20%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.